The neuromuscular blocking effect of Org 9426. A new intermediately-acting steroidal non-depolarising muscle relaxant in man
- PMID: 2035776
- DOI: 10.1111/j.1365-2044.1991.tb09539.x
The neuromuscular blocking effect of Org 9426. A new intermediately-acting steroidal non-depolarising muscle relaxant in man
Abstract
Org 9426, a new steroidal non-depolarising muscle relaxant, which is stable in solution, was studied in 30 anaesthetised (thiopentone, fentanyl, nitrous oxide) male patients, ASA 1 or 2. A dose-response curve for Org 9426 was constructed and the ED90, mean (SD), was found to be 0.36 (0.031) mg/kg. The onset of action was 3.8 (1.8) minutes, the clinical duration 17.4 (3.2) minutes, the total duration of action 31.9 (6.2) minutes and the recovery time 9.96 (3.2) minutes. No signs of histamine release or cardiovascular effects were observed. Org 9426 thus has a faster onset of action than vecuronium bromide or atracurium dibesylate.
Similar articles
-
Newer neuromuscular blocking drugs. An overview of their clinical pharmacology and therapeutic use.Drugs. 1992 Aug;44(2):182-99. doi: 10.2165/00003495-199244020-00003. Drugs. 1992. PMID: 1382013 Review.
-
Clinical observations on the neuromuscular blocking action of Org 9426, a new steroidal non-depolarizing agent.Br J Anaesth. 1990 Apr;64(4):521-3. doi: 10.1093/bja/64.4.521. Br J Anaesth. 1990. PMID: 2334630 Clinical Trial.
-
Neuromuscular effects of rocuronium bromide (Org 9426) during fentanyl and halothane anaesthesia.Anaesthesia. 1993 Feb;48(2):103-5. doi: 10.1111/j.1365-2044.1993.tb06844.x. Anaesthesia. 1993. PMID: 8460753
-
Cardiovascular and neuromuscular effects of three steroidal neuromuscular blocking drugs in dogs (ORG 9616, ORG 9426, ORG 9991).Anesth Analg. 1990 Apr;70(4):382-8. doi: 10.1213/00000539-199004000-00007. Anesth Analg. 1990. PMID: 1969251
-
Newer neuromuscular blocking agents: how do they compare with established agents?Drugs. 2001;61(7):919-42. doi: 10.2165/00003495-200161070-00003. Drugs. 2001. PMID: 11434449 Review.
Cited by
-
Clinical pharmacokinetics of rocuronium bromide.Clin Pharmacokinet. 1996 Sep;31(3):174-83. doi: 10.2165/00003088-199631030-00002. Clin Pharmacokinet. 1996. PMID: 8877248 Review.
-
Effect of Non-depolarizing Muscle Relaxants Rocuronium Versus Vecuronium in the Assessment of Post-Succinylcholine Complications in Surgeries Under General Anesthesia: A Randomized Double-Blind Study at a Tertiary Care Hospital.Cureus. 2021 Nov 21;13(11):e19793. doi: 10.7759/cureus.19793. eCollection 2021 Nov. Cureus. 2021. PMID: 34820250 Free PMC article.
-
Neuromuscular transmission and its pharmacological blockade. Part 1: Neuromuscular transmission and general aspects of its blockade.Pharm World Sci. 1997 Feb;19(1):1-12. doi: 10.1023/a:1008694726564. Pharm World Sci. 1997. PMID: 9089749 Review.
-
Newer neuromuscular blocking drugs. An overview of their clinical pharmacology and therapeutic use.Drugs. 1992 Aug;44(2):182-99. doi: 10.2165/00003495-199244020-00003. Drugs. 1992. PMID: 1382013 Review.
-
MRGPRX2 and Adverse Drug Reactions.Front Immunol. 2021 Aug 6;12:676354. doi: 10.3389/fimmu.2021.676354. eCollection 2021. Front Immunol. 2021. PMID: 34421893 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources